Amanda Williamson focuses her practice on complex intellectual property litigation in the life sciences industry relating to pharmaceuticals, biologics, biosimilars, and medical devices. Clients have entrusted Amanda to handle patent litigation that involves their market-leading and newly launched products. Outside of the life sciences, Amanda has been involved in patent infringement cases with a variety of technologies, including ink jet printing, RFID enabled devices, networked devices and related software, cellular devices, and standard essential wireless technologies.
Amanda has experience representing companies in US district courts across the country, the US Court of Appeals for the Federal Circuit, and the International Trade Commission (ITC). Amanda also works with clients on post-grant proceedings, including inter partes reviews and ex parte reexamination, and provides clients with strategic advice on patent portfolio management, freedom to operate analysis, and IP due diligence.
Following law school, Amanda served as a judicial law clerk to Judge James B. Zagel of the US District Court for the Northern District of Illinois. She also previously worked as a consultant at an accounting firm, where she assisted financial expert witnesses in analyzing and calculating damages in cases involving patent infringement and breach of contract claims.
Recognized, IAM Patent 1000: The World’s Leading Patent Professionals (2023, 2024)
Life Sciences Star, General Patent Litigation, LMG Life Sciences Awards Americas (2023, 2024)
Life Sciences Star, Intellectual Property, LMG Life Sciences (2022)
Member, Practice Group of the Year, Intellectual Property, Law360 (2019)
Director, Joffrey Ballet of Chicago